• 

  USA | Revised FDA Guidance on Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers

  Gallery

  USA | Revised FDA Guidance on Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers

  2022, Members-Only, Moderate Update, November 2022, USA
• 

USA | Revised FDA Guidance on Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers

Please login to view this page.

USA | Revised FDA Guidance on Expanded Access to Investigational Drugs for Treatment Use: Questions and Answersstuart.mccully2022-12-17T09:35:06+00:00

• 

  USA | New FDA Guidance on the Content of Human Factors (Usability) Information in Medical Device Marketing Submissions

  Gallery

  USA | New FDA Guidance on the Content of Human Factors (Usability) Information in Medical Device Marketing Submissions

  2022, Medical Devices, Members-Only, Moderate Update, November 2022, USA
• 

USA | New FDA Guidance on the Content of Human Factors (Usability) Information in Medical Device Marketing Submissions

Please login to view this page.

USA | New FDA Guidance on the Content of Human Factors (Usability) Information in Medical Device Marketing Submissionsstuart.mccully2022-12-17T09:39:22+00:00

• 

  USA | FDA Publishes Final Guidance on Procedures for Handling Post-Approval Studies Imposed by PMA Order

  Gallery

  USA | FDA Publishes Final Guidance on Procedures for Handling Post-Approval Studies Imposed by PMA Order

  2022, Medical Devices, Members-Only, USA
• 

USA | FDA Publishes Final Guidance on Procedures for Handling Post-Approval Studies Imposed by PMA Order

Please login to view this page.

USA | FDA Publishes Final Guidance on Procedures for Handling Post-Approval Studies Imposed by PMA Orderstuart.mccully2022-11-14T16:49:14+00:00

• 

  USA | FDA Finalises Guidance on Identifying When RWD/RWE Used in Submission

  Gallery

  USA | FDA Finalises Guidance on Identifying When RWD/RWE Used in Submission

  2022, August 2022, Members-Only, RWD to Support Reg Decisions, USA
• 

USA | FDA Finalises Guidance on Identifying When RWD/RWE Used in Submission

Please login to view this page.

USA | FDA Finalises Guidance on Identifying When RWD/RWE Used in Submissionstuart.mccully2022-09-12T09:18:44+00:00

• 

  USA | Final FDA Guidance – Patient Focused Drug Development

  Gallery

  USA | Final FDA Guidance – Patient Focused Drug Development

  2022, February 2022, Members-Only, Moderate Update, Patient Voice, RWD to Support Reg Decisions, USA
• 

USA | Final FDA Guidance – Patient Focused Drug Development

Please login to view this page.

USA | Final FDA Guidance – Patient Focused Drug Developmentstuart.mccully2022-08-07T16:41:47+00:00

• 

  USA – FDA Finalises Guidance on Principles for Selecting, Developing, Modifying, and Adapting PRO Instruments for Use in Medical Device Evaluation

  Gallery

  USA – FDA Finalises Guidance on Principles for Selecting, Developing, Modifying, and Adapting PRO Instruments for Use in Medical Device Evaluation

  2022, January 2022, Medical Devices, Members-Only, Moderate Update, USA
• 

USA – FDA Finalises Guidance on Principles for Selecting, Developing, Modifying, and Adapting PRO Instruments for Use in Medical Device Evaluation

Please login to view this page.

USA – FDA Finalises Guidance on Principles for Selecting, Developing, Modifying, and Adapting PRO Instruments for Use in Medical Device Evaluationstuart.mccully2022-08-07T16:54:16+00:00

• 

  USA | Draft FDA Guidance on the Correct Definition of a ‘Device’

  Gallery

  USA | Draft FDA Guidance on the Correct Definition of a ‘Device’

  2021, December 2021, Medical Devices, Members-Only, Minor Update, USA
• 

USA | Draft FDA Guidance on the Correct Definition of a ‘Device’

Please login to view this page.

USA | Draft FDA Guidance on the Correct Definition of a ‘Device’stuart.mccully2022-08-07T16:56:09+00:00

• 

  USA | Draft FDA Guidance: Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

  Gallery

  USA | Draft FDA Guidance: Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

  2021, December 2021, Digital Health, Members-Only, Moderate Update, USA
• 

USA | Draft FDA Guidance: Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

Please login to view this page.

USA | Draft FDA Guidance: Digital Health Technologies for Remote Data Acquisition in Clinical Investigationsstuart.mccully2022-08-07T16:56:55+00:00

• 

  USA – New FDA Draft Guidance for Industry: “Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products

  Gallery

  USA – New FDA Draft Guidance for Industry: “Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products

  2021, Members-Only, Moderate Update, RWD to Support Reg Decisions, September 2021, USA
• 

USA – New FDA Draft Guidance for Industry: “Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products

Please login to view this page.

USA – New FDA Draft Guidance for Industry: “Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Productsstuart.mccully2022-08-07T17:18:58+00:00